author-photo

Vicente Carañana

16

Papers

831

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trial.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

2019 Critical Reviews in Oncology Hematology
Show All
- Source
- Cite
- Save
Citations (101)
Abstract CT219: Neoadjuvant letrozole and palbociclib in stage II-IIIB HR[+]/HER2[-] breast cancer with Oncotype DX Recurrence Score®(RS) 18-25 or 26-100. Analysis of RS changes at surgery (DxCARTES trial)

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (2)
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

2018 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (120)
Predictive tools for bevacizumab therapy in patients with aggressive HER 2-negative metastatic breast cancer: 2-years results from an observational study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract S3-01: IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.

2016 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

2014 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (529)
Abstract P3-15-02: A prospective, open label, non-comparative trial to determine the incidence of chemotherapy-induced nausea and vomiting associated with the docetaxel-cyclophosphamide regimen in early breast cancer patients. Results from the GEICAM 2009-02 study

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)